Tina Rizack

601 total citations
20 papers, 336 citations indexed

About

Tina Rizack is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Tina Rizack has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Tina Rizack's work include Breast Cancer Treatment Studies (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Tina Rizack is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Tina Rizack collaborates with scholars based in United States and China. Tina Rizack's co-authors include Gianna Wilkie, Anthony Mega, Robert D. Legare, Jorge J. Castillo, Don S. Dizon, Heather A. Lankes, Robert V. Higgins, Ashley Stuckey, David Berz and Gerald A. Colvin and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and JAMA Oncology.

In The Last Decade

Tina Rizack

20 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tina Rizack United States 9 127 63 56 54 50 20 336
Aida Moeini United States 14 104 0.8× 22 0.3× 42 0.8× 69 1.3× 35 0.7× 31 519
Erin A. Blake United States 14 177 1.4× 29 0.5× 76 1.4× 31 0.6× 20 0.4× 31 474
Kristin J. Moore United States 7 115 0.9× 19 0.3× 75 1.3× 16 0.3× 23 0.5× 32 249
Umut Varol Türkiye 14 387 3.0× 16 0.3× 86 1.5× 29 0.5× 34 0.7× 56 581
Wen‐Shiung Liou Taiwan 11 58 0.5× 8 0.1× 65 1.2× 34 0.6× 25 0.5× 26 306
Angela Bowman United Kingdom 12 118 0.9× 14 0.2× 119 2.1× 18 0.3× 21 0.4× 16 407
Michael Steel United Kingdom 11 66 0.5× 20 0.3× 38 0.7× 20 0.4× 48 1.0× 23 563
Laura L. Holman United States 14 156 1.2× 11 0.2× 77 1.4× 28 0.5× 66 1.3× 60 635
Melissa M. Hudson United States 11 94 0.7× 20 0.3× 24 0.4× 178 3.3× 175 3.5× 20 429
Mohammed Ibrahim Canada 13 281 2.2× 15 0.2× 77 1.4× 24 0.4× 51 1.0× 42 463

Countries citing papers authored by Tina Rizack

Since Specialization
Citations

This map shows the geographic impact of Tina Rizack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Rizack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Rizack more than expected).

Fields of papers citing papers by Tina Rizack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina Rizack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Rizack. The network helps show where Tina Rizack may publish in the future.

Co-authorship network of co-authors of Tina Rizack

This figure shows the co-authorship network connecting the top 25 collaborators of Tina Rizack. A scholar is included among the top collaborators of Tina Rizack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Rizack. Tina Rizack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizack, Tina, et al.. (2018). Sexuality, fertility and pregnancy following breast cancer treatment. Gland Surgery. 7(4). 404–410. 14 indexed citations
2.
Gruenigen, Vivian E. von, Helen Huang, Jan H. Beumer, et al.. (2017). Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer – An NRG oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 144(3). 459–467. 53 indexed citations
3.
4.
Raker, Christina, et al.. (2016). Predicting Breast Tumor Size for Pre-operative Planning: Which Imaging Modality is Best?. The Breast Journal. 23(1). 52–58. 19 indexed citations
5.
Wilkie, Gianna, et al.. (2016). Medical Marijuana Use in Oncology. JAMA Oncology. 2(5). 670–670. 75 indexed citations
6.
7.
Witherby, Sabrina, et al.. (2015). Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015. Seminars in Radiation Oncology. 26(1). 59–70. 9 indexed citations
8.
Roque, Dario R., Beth Cronin, Katina Robison, et al.. (2013). The effects of age on treatment and outcomes in women with stages IB1–IIB cervical cancer. Journal of Geriatric Oncology. 4(4). 374–381. 3 indexed citations
9.
Sinclair, Natalie, Maysa Abu‐Khalaf, George Somlo, et al.. (2013). Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+ breast cancer: A BrUOG study.. Journal of Clinical Oncology. 31(15_suppl). 619–619. 6 indexed citations
10.
Robison, Katina, Tina Rizack, Robert D. Legare, et al.. (2013). Outcomes for Women Receiving Bevacizumab for Treatment of Ovarian Cancer Versus Other Solid Tumors at an Academic Oncology Center. 6(1-2). 21–24. 1 indexed citations
11.
12.
Stuckey, Ashley, M.E. Schutzer, Tina Rizack, & Don S. Dizon. (2012). Locally Advanced Vulvar Cancer in Elderly Women. American Journal of Clinical Oncology. 36(3). 279–282. 6 indexed citations
13.
Rizack, Tina & Karen Rosene‐Montella. (2012). Special Hematologic Issues in the Pregnant Patient. Hematology/Oncology Clinics of North America. 26(2). 409–432. 5 indexed citations
14.
Kamalakaran, Sitharthan, Kimberly Lezon-Geyda, Vinay Varadan, et al.. (2011). Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens.. Journal of Clinical Oncology. 29(27_suppl). 46–46. 2 indexed citations
15.
Berz, David, Tina Rizack, Sherry Weitzen, et al.. (2011). Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract. Clinical Medicine Insights Oncology. 6. 11–8. 25 indexed citations
16.
Rizack, Tina, Maysa Abu‐Khalaf, Robert D. Legare, et al.. (2010). Neoadjuvant therapy for stage II-III breast cancer with weekly nab-paclitaxel, every-three-week carboplatin, and targeted agents: Interim dose delivery and toxicity data.. Journal of Clinical Oncology. 28(15_suppl). e11010–e11010. 2 indexed citations
17.
Matoso, Andrés, Tina Rizack, & Diana O. Treaba. (2010). Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature. Diagnostic Pathology. 5(1). 6–6. 9 indexed citations
18.
Castillo, Jorge J., Tina Rizack, & Diana O. Treaba. (2010). Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma. Pathology Research International. 2011. 1–5. 2 indexed citations
19.
Rizack, Tina, Anthony Mega, Robert D. Legare, & Jorge J. Castillo. (2009). Management of hematological malignancies during pregnancy. American Journal of Hematology. 84(12). 830–841. 62 indexed citations
20.
Rizack, Tina, Anthony Mega, & David Berz. (2009). Is squamous cell histology an adverse prognosticator for survival of malignancies of the upper urinary tract?. Journal of Clinical Oncology. 27(15_suppl). 6617–6617. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aida Moeini Breakdown of academic impact, for papers by Erin A. Blake Breakdown of academic impact, for papers by Kristin J. Moore Breakdown of academic impact, for papers by Umut Varol Breakdown of academic impact, for papers by Wen‐Shiung Liou Breakdown of academic impact, for papers by Angela Bowman Breakdown of academic impact, for papers by Michael Steel Breakdown of academic impact, for papers by Laura L. Holman Breakdown of academic impact, for papers by Melissa M. Hudson Breakdown of academic impact, for papers by Mohammed Ibrahim
Rankless by CCL
2026